Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology’s Solid Tumor Medical Advisory Board
Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, proudly announces that Dr. Gerard Blobe,
Read MoreVivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, proudly announces that Dr. Gerard Blobe,
Read MoreStudies demonstrate that approx. 1 in 3 patients with renal denervation do not have a meaningful drop in Blood Pressure
Read MorePost Views: 75 Explora BioLabs, a national provider of industry-leading preclinical vivarium research space and management services based in San
Read MorePost Views: 193 Biopharma Corporation (iMBP) announces it has teamed with Amazon Web Services (AWS) to aid in the development
Read MorePost Views: 77 Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, will present at the upcoming 2022
Read MorePost Views: 92 GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the
Read MorePost Views: 128 Gens & Associates, one of the most respected benchmarking and advisory firms in Life Sciences, is extending
Read MorePost Views: 62 TeselaGen Biotechnology announced today a two-year contract with BioMADE, the Department of Defense-sponsored bioindustrial Manufacturing Innovation Institute,
Read MorePost Views: 74 CS Analytical Laboratory, the world’s only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to
Read MorePost Views: 80 More than 90 percent of people diagnosed with lung cancer do not survive the disease, usually because
Read More